Suppr超能文献

[甲状腺激素抵抗与桥本甲状腺炎]

[Resistance to thyroid hormone and Hashimoto's thyroiditis].

作者信息

Guerra-Argüero Laura Margarita, Gutiérrez-Saucedo José Alfredo, Gómez-Coello Annel, Gállego-Suárez Cecilia, Vázquez Mellado-Septién Alberto

机构信息

Servicio de Endocrinología, Consulta Externa, Hospital Ángeles de Querétaro, Quéretaro, Mexico.

出版信息

Cir Cir. 2011 Sep-Oct;79(5):453-7.

Abstract

BACKGROUND

Resistance to thyroid hormone (RTH) is a rare condition characterized by elevation of thyroid stimulating hormone (TSH) and thyroid hormones (TH). Its association with Hashimoto's thyroiditis was described in 1993 and occurs in 1 of 1.3 million births.

CLINICAL CASE

We present a female patient with a family history of hypothyroidism. The patient's condition began in 2008 with symptoms of hyperthyroidism, elevated triiodothyronine (T3), thyroxine (T4) and TSH levels. Thyroid scan showed hypermetabolic activity and she was positive for anti-peroxidase antibodies (anti-TPO). After administration of thiamazole, TSH increased. In 2009 she was diagnosed with clinical hypothyroidism, high levels of TSH, and normal T3 and T4 levels. Levothyroxine was prescribed but TSH increased and she presented clinical signs of hyperthyroidism. Patient abandoned treatment after 1 month. Her symptoms fluctuated among hyperthyroidism, euthyroidism and hypothyroidism. In 2010 she presented tachycardia, weight loss, and high T3, T4 and TSH levels. Thyrotropin-secreting adenoma (TSHoma) was suspected and ruled out by magnetic resonance imaging (MRI). Thyrotropin releasing hormone (TRH) test was performed. TSH increased and the α-subunit of pituitary hormones retained low levels.

CONCLUSIONS

RTH diagnosis requires exclusion of a TSHoma because both present a similar pattern according to thyroid tests. The association between Hashimoto's thyroiditis and RTH is not well known. This pathological condition has a mutated TRβ gene in 75% of the cases.

摘要

背景

甲状腺激素抵抗(RTH)是一种罕见病症,其特征为促甲状腺激素(TSH)和甲状腺激素(TH)升高。1993年描述了它与桥本甲状腺炎的关联,在130万例出生中发生率为1例。

临床病例

我们报告一名有甲状腺功能减退家族史的女性患者。该患者的病情始于2008年,出现甲状腺功能亢进症状,三碘甲状腺原氨酸(T3)、甲状腺素(T4)和TSH水平升高。甲状腺扫描显示代谢亢进活动,抗过氧化物酶抗体(抗TPO)呈阳性。服用甲巯咪唑后,TSH升高。2009年她被诊断为临床甲状腺功能减退,TSH水平高,T3和T4水平正常。开具了左甲状腺素,但TSH升高,她出现了甲状腺功能亢进的临床体征。患者在1个月后停止治疗。她的症状在甲状腺功能亢进、甲状腺功能正常和甲状腺功能减退之间波动。2010年,她出现心动过速、体重减轻,T3、T4和TSH水平高。怀疑为促甲状腺激素分泌腺瘤(TSHoma),磁共振成像(MRI)排除了该诊断。进行了促甲状腺激素释放激素(TRH)试验。TSH升高,垂体激素的α亚基保持低水平。

结论

RTH的诊断需要排除TSHoma,因为根据甲状腺检查两者呈现相似模式。桥本甲状腺炎与RTH之间的关联尚不清楚。这种病理状况在75%的病例中有TRβ基因突变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验